Cermline Mutation of RET Gene in A Multiple Endocrine Neoplasia Type 2A ( MEN2A ) Family.
- Author:
Hee Young YANG
1
;
Young Jin PARK
;
Hyuk Joon KWON
;
Kuk Jin CHOE
Author Information
1. Korean Hereditary Tumor Registry, Cancer Research Institute, Korea.
- Publication Type:Original Article
- Keywords:
MEN 2A;
Medullary thyroid cancer;
RET gene;
Calcitonin
- MeSH:
Calcitonin;
Calcium;
Codon;
Diagnosis;
Germ-Line Mutation;
Humans;
Hyperplasia;
Multiple Endocrine Neoplasia Type 2a*;
Multiple Endocrine Neoplasia*;
Pheochromocytoma;
Thyroid Neoplasms
- From:Journal of the Korean Cancer Association
1999;31(5):867-875
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Multiple Endocrine Neoplasia Type 2A (MEN 2A) is an autosomal dominant disease characterized by development of the medullary thyroid cancer, adrenal pheochromocytoma and parathyroid hyperplasia. Gennline mutations of RET gene, which cause a susceptibility to MEN 2A syndrome, have been reported in MEN 2A families. The identification of germline mutation in family members with hereditary tumor syndrome makes the presymptomatic diagnosis possible. However, there are only a few reports on the germline mutation of RET gene in Korean patients with MEN 2A. This study was performed to investigate the germline mutation of RET gene in a Korean MEN 2A family. MATERIALS AND METHODS: Blood samples were taken from family members of a MEN 2A family. Mutational status was investigated using single strand conformation polymorphism (SSCP) method, and following direct sequencing. Basal level of calcitonin was measured, and calcium provocation test was done when the result of basal level of calcitonin was equivocal. RESULTS: A missense type germline mutation of RET gene was identified at codon 634 (TGC->TGG) in eight patients from the family. All patients with the germline mutation of RET gene showed elevation of calcitonin level either in basal test or in calcitonin provocation test. CONCLUSION: We identified a germline mutation of RET gene in a family with MEN 2A, and it would make the accurate presymptomatic diagnosis possible.
